Nomura Holdings’s Amedisys AMED Stock Holding History

Nomura Holdings’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-86,000	Closed	-$12.5M	–	2221
2021 Q3	$12.5M	Buy	+86,000	New	+$17.9M	0.03%	329
2021 Q2	–	Sell	-28,000	Closed	-$7.44M	–	1995
2021 Q1	$7.44M	Buy	+28,000	New	+$7.9M	0.02%	436

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Nomura Holdings's AMED Position: Q1 2025 in Review

Nomura Holdings sold out of Amedisys (AMED) in Q1 2025, closing a stake of 4,346 shares — an estimated $395K sold.

Nomura Holdings first reported a position in AMED in Q2 2013 and held it in 12 quarters. The position peaked at $4.69M in Q4 2023. 304 funds tracked by Wall St. Rank hold AMED as of Q1 2025.

Nomura Holdings reported no remaining Amedisys position as of Q1 2025 after selling out during the quarter.
Nomura Holdings sold 4,346 Amedisys shares in Q1 2025, an estimated $395K.
Nomura Holdings first reported a position in Amedisys in Q2 2013 and held it in 12 quarters.
Nomura Holdings's Amedisys position peaked at $4.69M in Q4 2023.
304 funds tracked by Wall St. Rank held Amedisys as of Q1 2025.

Based on Nomura Holdings's 13F filing for Q1 2025, filed 15 May 2025.